Testing effectiveness (Phase 2)Study completedNCT01414114
What this trial is testing
Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder
Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 37